Abstract
Purpose
Previous studies have shown that approximately 10% of nasopharyngeal cancer (NPC) patients die within a year of disease onset, and that age is an independent predictor. However, no predictive model has been developed. We aimed to establish novel prognostic models to predict the 1-year cancer-specific survival (CSS) of young, middle-aged, and older patients with NPC after radiotherapy.
Methods
The data of 2822 NPC patients who underwent radiotherapy between 2004 and 2015 were reviewed from the surveillance, epidemiology, and end results database. We divided them into young, middle-aged, and older people groups according to age (< 44 years, 45–59 years, and ≥ 60 years, respectively). Multivariate analyses were performed, and prognostic models were constructed.
Results
Multivariate analyses indicated that age, ethnicity, histological subtype, T, and M stage were independent predictors of 1-year CSS in the older people group. In contrast, ethnicity and age were not found to have predictive value in the young and middle-aged groups, respectively. Accordingly, three prognostic models with excellent predictive values were established for the three groups (C-indices: 0.791 [95% CI 0.722–0.859], 0.763 [95% CI 0.721–0.806] and 0.723 [95% CI 0.683–0.763], respectively). These predictive values are higher than those of the eighth edition American joint committee cancer tumor-node-metastasis (TNM) classification system.
Conclusion
Three prognostic models for predicting the 1-year CSS of young, middle-aged, and older NPC patients after radiotherapy showed better predictive power than the TNM classification system. These models may guide treatment strategies and clinical decision-making in different cohorts.
Similar content being viewed by others
References
Zhu Y, Song X, Li R, Quan H, Yan L (2019) Assessment of nasopharyngeal cancer in young patients aged ≤ 30 years. Front Oncol 9:1179
Pan JJ, Ng WT, Zong JF et al (2016) Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(21):3307–3315
Carioli G, Negri E, Kawakita D, Garavello W, La Vecchia C, Malvezzi M (2017) Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: focus on low-risk areas. Int J Cancer 140(10):2256–2264
Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. The Lancet 394(10192):64–80
Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48(2):329–337
Kam MK, Chau RM, Suen J, Choi PH, Teo PM (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56(1):145–157
Jiang F, Jin T, Feng XL, Jin QF, Chen XZ (2015) Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang cancer hospital’s experience. J Cancer Res Ther 11(Suppl 2):C179-184
Li YQ, Tian YM, Tan SH et al (2018) Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy. JCO 36(9):891–899
Tang XR, Li YQ, Liang SB et al (2018) Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol 19(3):382–393
Tang LQ, Li CF, Li J et al (2016) Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djv291
Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR (2020) Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients. Laryngoscope 130(3):E83–E88
Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M (2000). Age standardization of Rates: a new WHO standard GPE. Discussion Paper Series. Geneva: World Health Organization
Pfster DG, Spencer S, Adelstein D et al (2019). NCCN Clinical Practice Guidelines in Oncology
Wang CC, Yang CC, Yeh SA et al (2020) The impact of insurance and marital status on survival in patients with nasopharyngeal carcinoma. Biology (Basel). 9(4):84
Guo R, Wu H, Wang J et al (2019) Lymph node status and outcomes for nasopharyngeal carcinoma according to histological subtypes: a SEER population-based retrospective analysis. Adv Ther 36(11):3123–3133
Xu BB, Lu J, Zheng ZF et al (2019) The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer 22(5):1016–1028
Wu LR, Liu YT, Jiang N et al (2017) Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol 69:26–32
Lv JW, Huang XD, Chen YP et al (2018) A national study of survival trends and conditional survival in nasopharyngeal carcinoma: analysis of the national population-based surveillance epidemiology and end results registry. Cancer res and treat 50(2):324–334
Lv JW, Zhou GQ, Chen YP et al (2017) Refining the role of lymph node biopsy in survival for patients with nasopharyngeal carcinoma: population-based study from the surveillance epidemiology and end-results registry. Ann Surg Oncol 24(9):2580–2587
Wu LR, Zhang XM, Xie XD, Lu Y, Wu JF, He X (2019) Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: results from a non-endemic cohort with 10-year follow-up. Oral Oncol. 98:141–146
Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. JCO 26(8):1364–1370
Dong D, Tang L, Li ZY et al (2019) Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 30(3):431–438
Zhang LL, Huang MY, Li Y et al (2019) Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. EBioMedicine 42:270–280
Huang XD, Zhou GQ, Lv JW et al (2018) Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis. Radiother Oncol 129(2):389–395
Wu SG, Lian CL, Wang J et al (2019) The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med 7(23):768
Liu Z, Chang ET, Liu Q et al (2017) Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area. Cancer 123(14):2716–2725
Jørgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7):1353–1360
García-Lorenzo J, Farre N, Codina A, Gallego O, De Vega M, León X (2017) Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area. Clin Transl Oncol 19(6):777–783
Au KH, Ngan RKC, Ng AWY et al (2018) Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral Oncol 77:16–21
Tsao SW, Yip YL, Tsang CM et al (2014) Etiological factors of nasopharyngeal carcinoma. Oral Oncol 50(5):330–338
Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ (2017) Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer 36(1):90
Acknowledgements
The authors would like to thank all the medical staff who contributed to the maintenance of the medical record database.
Funding
None.
Author information
Authors and Affiliations
Contributions
QZ: conceived the study, analyzed the data, and drafted the manuscript. LZ: analyzed the data, and drafted the manuscript. ZL: helped critically revise the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial relationships or conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, Qx., Zhuang, Lp. & Lin, Zy. Prognostic models for 1-year survival of NPC after radiotherapy in different ages. Eur Arch Otorhinolaryngol 278, 4955–4965 (2021). https://doi.org/10.1007/s00405-021-06730-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06730-8